967 results on '"Tessitore, Alessandro"'
Search Results
2. Altered domain-specific striatal functional connectivity in patients with Parkinson’s disease and urinary symptoms
3. Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia
4. Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients
5. Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
6. Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study
7. Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease
8. Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease
9. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
10. Resting-state network connectivity changes in drug-naive Parkinson’s disease patients with probable REM sleep behavior disorder
11. Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?
12. The Italian tremor Network (TITAN): rationale, design and preliminary findings
13. SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum
14. Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults
15. Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study
16. Criteria for identification of advanced Parkinson’s disease: the results of the Italian subgroup of OBSERVE-PD observational study
17. Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
18. Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
19. Lessons from the past to understand the future
20. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
21. Advanced Parkinson’s disease treatment patterns in Italy: an observational study interim analysis
22. Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta‐Analysis
23. Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease
24. Correction to: The Italian tremor Network (TITAN): rationale, design and preliminary findings
25. Fatigue in hypokinetic, hyperkinetic, and functional movement disorders
26. Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
27. Subjective memory decline in Parkinson's disease patients with and without fatigue
28. Elderly Onset of Functional Motor Disorders: Clinical Correlates from the Italian Registry
29. Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
30. Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients
31. Correction to: The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients
32. Flexible brain dynamics underpins complex behaviours as observed in Parkinson’s disease
33. Disconnectome of the migraine brain: a “connectopathy” model
34. Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue
35. The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients
36. A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG
37. Validation of the Italian version of the PSP Quality of Life questionnaire
38. Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy
39. Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study
40. Disfluency and speech management in Italian patients with early-stage Parkinson's Disease
41. Migraine Treatment: Towards New Pharmacological Targets
42. Neuroimaging in Migraines
43. Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment
44. Olfactory Loss and Brain Connectivity after COVID-19: Structural Follow-Up at One Year
45. Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials
46. Catechol O-Methyltransferase val158-met Genotype and Individual Variation in the Brain Response to Amphetamine
47. Resting-state brain networks in patients with Parkinson's disease and impulse control disorders
48. Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients
49. Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
50. Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.